Abstract:Dezocine is a partial MOR agonist previously used clinically in the USA and currently in China. It has been proposed that dezocine be reintroduced to clinical use in the USA, as an analgesia and/or an additional tool to treat opioid use disorder. To consider the clinical reintroduction of dezocine knowing its abuse liability is important. In this review, we found no reports of abuse, dependence or overdose in the English literature, and a small number of cases of dependence in the Chinese literature. If it is less or non‐addictive than other opioids, its short half‐life would allow it to bridge to other medication assisted therapies, facilitate tapering of opioid use and perhaps be used as a rescue medication in those trying to reduce opioid use. Aims Opioid use disorder (OUD) remains a serious public health problem. Opioid maintenance treatment is effective but under‐utilized, hard to access under existing federal regulations, and, once patients achieve OUD stability, challenging to discontinue. Fewer than 2% of persons with OUD stop using opioids completely. There have been calls from public advocacy groups, governmental agencies, and public health officials for new treatments for OUD. Dezocine, a non‐scheduled opioid previously used in the United States and currently widely prescribed in China for pain management, could be a candidate for a novel OUD treatment medication in the U.S. Nonetheless, to date, there have been no reviews of the clinical and preclinical literature detailing dezocine's abuse potential, a key consideration in assessing its clinical utility. Discussion There are no English language reports of human abuse, dependence, or overdose of dezocine, despite years of extensive clinical use. There are a few case reports of dezocine abuse in the Chinese literature, but there are no reports of overdose deaths. Dezocine is perceived as an opioid and is "liked" by opioid‐experienced human and non‐human primates, properties that are not dose‐dependent and are mitigated by ceiling effects—higher doses do not result in more "liking." There is little withdrawal, spontaneous or precipitated, in humans, monkeys, rats, or mice treated chronically with dezocine alone. However, at some doses, dezocine can precipitate withdrawal in humans and monkeys dependent on other opioids. In rodents, dezocine reduces the severity of morphine withdrawal and the rewarding properties of other opioids. Conclusions Although dezocine is reinforcing in humans and monkeys with prior or concurrent opioid use within a restricted dose range, there are only a few anecdotal reports of dezocine abuse despite of the long history of use in humans. Given the evidence of dezocine's limited abuse potential, it could be useful both as a treatment for OUD. However, in‐depth studies would be required for dezocine to be re‐considered for clinical use.

Advances of the Clinical Application of Dezocine

Dezocine For Preventing Postoperative Pain: A Meta-Analysis Of Randomized Controlled Trials

Dezocine Attenuates the Remifentanil-Induced Postoperative Hyperalgesia by Inhibition of Phosphorylation of CaMKⅡα.

Dezocine as a potent analgesic: overview of its pharmacological characterization

Efficacy and safety of dezocine in postoperative pain relief: Systematic review and Meta-analysis

Dezocine Exhibits Antihypersensitivity Activities in Neuropathy Through Spinal Μ-Opioid Receptor Activation and Norepinephrine Reuptake Inhibition.

Randomized and Double -Blind Controlled Clinical Trial of Dezocine Injection for Analgesia

Analgesic and Sedative Effects of Dezocine and Midazolam During Vitrectomy.

Analyzing the application of dezocine combined with psychological care in the postoperative pain management of patients with hemifacial spasm

Advance of the study on anesthesia and analgesia of pentazocine

Clinical study on dezocine and sufentanil for postoperative analgesia in upper-abdominal surgery or hip replacement surgery

Dezocine before induction enhances the postoperative analgesic effect in oral cancer patients

Revisiting dezocine for opioid use disorder: A narrative review of its potential abuse liability

Clinical Observation of Dezocine Combined with Flurbiprofen for Postoperative Analgesia after Abdominal Surgeries: a Prospective Study

Effect of Dezocine on Postoperative Pain in Laparoscopic Patients

Efficacy of Dezocine in Enhancing Postoperative Patient-Controlled Epidural Analgesia with Bupivacaine

Reprint Of: Efficacy and Safety of Different Doses of Dezocine for Preemptive Analgesia in Gynecological Laparoscopic Surgeries: A Prospective, Double Blind and Randomized Controlled Clinical Trial.

Application of dezocine patient-controlled epidural analgesia in postoperative analgesia in patients with total myomectomy

Research of the Treatment Effects on Patient's Visceral Pain by Dezocine in Laparoscopic Cholecystectomy

Dezocine Alleviates Morphine-Induced Dependence in Rats

Advances of the Pharmacology and Clinical Use of Dexmedetomidine